Drugs that contain Eptifibatide
1. Integrilin patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5686570 | MSD SUB MERCK | Platelet aggregation inhibitors |
Nov, 2014
(9 years ago) | |
| US5756451 | MSD SUB MERCK | Platelet aggregation inhibitors |
Nov, 2014
(9 years ago) | |
| US5747447 | MSD SUB MERCK | Stable polypeptide composition |
May, 2015
(9 years ago) | |
| US5968902 | MSD SUB MERCK | Platelet aggregation inhibitors |
Jun, 2015
(8 years ago) | |
| US5807825 | MSD SUB MERCK | Platelet aggregation inhibitors |
Sep, 2015
(8 years ago) | |
Market Authorisation Date: 18 May, 1998
Treatment: Treatment of platelet associated ischemic disorders; Platelet aggregation inhibitors
Dosage: INJECTABLE;INJECTION
How can I launch a generic of INTEGRILIN before it's drug patent expiration?
More Information on Dosage
INTEGRILIN family patents
